InsidersTradesSigma
셀레믹스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 셀레믹스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 셀레믹스 has logged 22 reports. Market capitalisation: €104.7bn. The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: 김효기. Every trade is openly available.
21
Insider Decl.
n/a
Thresholds
€9m
6 ops.
Buy Volume
€1m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,217 of 28,199 companies
25.9
score / 100
Value26
Quality26
FCF yld-3.3%
Earn yld-3.5%
EV/EBITDA·
ROE-37%
Gross mgn50%
Net mgn-70%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations22 total
Other
Other(filed)
ShareKRXDART:20260507000379
1,021,143 sharesKRXDART:20260507000371
22 of 22 declarations
About 셀레믹스
셀레믹스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the diagnosis and treatment of diseases.